Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study

Conditions:   Oral Squamous Cell Carcinoma;   Carcinoma of Buccal Mucosa;   Tongue Cancers;   Head and Neck Cancers
Interventions:   Drug: Celecoxib;   Drug: Erlotinib;   Drug: Celecoxib + Erlotinib
Sponsor:   Tata Memorial Hospital
Recruiting - verified April 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1VNdmy2
via IFTTT